Connection

Kwok-Yung Yuen to Neutralization Tests

This is a "connection" page, showing publications Kwok-Yung Yuen has written about Neutralization Tests.
Connection Strength

0.333
  1. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J Clin Virol. 2009 May; 45(1):54-60.
    View in: PubMed
    Score: 0.145
  2. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J Infect. 2013 Aug; 67(2):130-40.
    View in: PubMed
    Score: 0.048
  3. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine. 2005 Oct 10; 23(42):4959-68.
    View in: PubMed
    Score: 0.029
  4. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum. EBioMedicine. 2021 Sep; 71:103544.
    View in: PubMed
    Score: 0.021
  5. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat Commun. 2021 07 09; 12(1):4210.
    View in: PubMed
    Score: 0.021
  6. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020 08; 584(7821):450-456.
    View in: PubMed
    Score: 0.020
  7. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol. 2014 Jul; 88(14):7796-805.
    View in: PubMed
    Score: 0.013
  8. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine. 2008 Mar 20; 26(13):1644-51.
    View in: PubMed
    Score: 0.008
  9. Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines. Virology. 2006 Sep 15; 353(1):6-16.
    View in: PubMed
    Score: 0.007
  10. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol. 2006 Jan; 78(1):1-8.
    View in: PubMed
    Score: 0.007
  11. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 2005 Mar; 79(5):2678-88.
    View in: PubMed
    Score: 0.007
  12. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003 Oct 10; 302(5643):276-8.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.